Fresenius Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Fresenius Medical Care
FMS Stock  USD 23.82  0.07  0.29%   
Fresenius Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Fresenius Medical's valuation are provided below:
Gross Profit
4.9 B
Profit Margin
0.0366
Market Capitalization
13.9 B
Enterprise Value Revenue
1.0402
Revenue
19.6 B
There are over one hundred nineteen available fundamental signals for Fresenius Medical Care, which can be analyzed over time and compared to other ratios. All traders should verify Fresenius Medical's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 10.1 B in 2025. Enterprise Value is likely to drop to about 14.9 B in 2025

Fresenius Medical Total Revenue

11.73 Billion

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0136 or PTB Ratio of 0.84. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Build AI portfolio with Fresenius Stock
Check out the analysis of Fresenius Medical Correlation against competitors.

Fresenius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding664.6 M674.9 M672.7 M
Slightly volatile
Total Assets19.3 B33.6 B24.7 B
Slightly volatile
Short and Long Term Debt Total6.5 B11 B8.8 B
Slightly volatile
Other Current Liabilities1.9 B3.1 B2.2 B
Slightly volatile
Total Current Liabilities3.8 B5.7 B4.7 B
Slightly volatile
Total Stockholder Equity7.8 B14.6 B9.8 B
Slightly volatile
Property Plant And Equipment Net7.6 B7.3 B4.7 B
Slightly volatile
Net Debt5.9 B9.8 B7.9 B
Slightly volatile
Retained Earnings11.8 B11.3 B7.8 B
Slightly volatile
Accounts Payable565.5 M984.3 M703.6 M
Slightly volatile
Cash616.2 M1.2 B893.8 M
Slightly volatile
Non Current Assets Total14.3 B25.6 B18.4 B
Slightly volatile
Cash And Short Term Investments691 M1.3 B1 B
Slightly volatile
Net Receivables2.5 B3.4 B3.1 B
Slightly volatile
Common Stock Total Equity304.7 M336.8 M300.3 M
Slightly volatile
Liabilities And Stockholders Equity19.3 B33.6 B24.7 B
Slightly volatile
Non Current Liabilities Total7.4 B12.1 B9.5 B
Slightly volatile
Inventory1.1 B2.1 B1.4 B
Slightly volatile
Other Current Assets711.4 M1.1 B748.9 M
Slightly volatile
Other Stockholder Equity3.2 B3.3 B3.2 B
Slightly volatile
Total Liabilities11.1 B17.8 B14.2 B
Slightly volatile
Property Plant And Equipment Gross17.9 B18.8 B6.5 B
Slightly volatile
Total Current Assets5 B7.9 B6.3 B
Slightly volatile
Short Term Debt1.1 B1.2 B1.4 B
Slightly volatile
Intangible Assets1.3 B1.4 B1.1 B
Pretty Stable
Common Stock261 M337.4 M279.9 M
Slightly volatile
Other Liabilities3.2 B3.1 B2 B
Slightly volatile
Other Assets502.4 M427.8 M646.5 M
Slightly volatile
Long Term Debt5.8 B6.3 B6.4 B
Pretty Stable
Property Plant Equipment4 B7.3 B4.9 B
Slightly volatile
Good Will14.4 B15.2 B11.8 B
Slightly volatile
Short Term Investments155.5 M163.1 M126.5 M
Slightly volatile
Long Term Investments911.9 M1.4 B803.3 M
Slightly volatile
Short and Long Term Debt548.5 M577.4 M3.1 B
Slightly volatile
Long Term Debt Total9.7 B9.8 B8.4 B
Slightly volatile
Capital Surpluse2.8 B3.3 B3.7 B
Slightly volatile
Net Invested Capital20.7 B21.4 B18.3 B
Slightly volatile
Cash And Equivalents383.2 M342.9 M420.1 M
Very volatile
Net Working Capital1.5 B2.3 B1.3 B
Slightly volatile
Capital Stock237.5 M264.1 M296.9 M
Slightly volatile

Fresenius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue11.7 B19.3 B14.8 B
Slightly volatile
Gross Profit3.7 B4.8 B4.6 B
Slightly volatile
Operating Income1.6 B1.4 B2 B
Slightly volatile
EBIT1.6 B1.5 B2 B
Slightly volatile
EBITDA2.3 B3.2 B3 B
Slightly volatile
Net Income708.2 M537.9 M912.9 M
Very volatile
Depreciation And Amortization1.8 B1.7 B1.1 B
Slightly volatile
Selling General Administrative2.2 B2.4 B2.4 B
Slightly volatile
Other Operating Expenses10.5 B17.9 B13 B
Slightly volatile
Research Development110.6 M183.5 M142 M
Slightly volatile
Cost Of Revenue8.3 B14.6 B10.3 B
Slightly volatile
Total Operating Expenses2.2 B3.4 B2.7 B
Slightly volatile
Income Before Tax1.2 B1.1 B1.5 B
Very volatile
Net Income Applicable To Common Shares902.8 M537.9 M995.7 M
Pretty Stable
Net Income From Continuing Ops1.1 B740.9 M1.3 B
Slightly volatile
Tax Provision347.3 M316.1 M469.6 M
Slightly volatile
Interest Income68 M71.6 M282.5 M
Slightly volatile
Reconciled Depreciation1.6 B1.7 B1.2 B
Slightly volatile
Selling And Marketing Expenses636.1 M776.5 M789.5 M
Slightly volatile

Fresenius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.5 B1.4 B909.2 M
Slightly volatile
Depreciation1.8 B1.7 B1.1 B
Slightly volatile
Dividends Paid227.6 M349.2 M278.9 M
Slightly volatile
Capital Expenditures1 B699.4 M1.4 B
Very volatile
Total Cash From Operating Activities1.6 B2.4 B2 B
Slightly volatile
Net Income856.3 M740.9 M1.1 B
Pretty Stable
End Period Cash Flow617.2 M1.2 B895.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.630.66471.1591
Slightly volatile
Dividend Yield0.01360.02720.018
Slightly volatile
PTB Ratio0.840.88181.8136
Slightly volatile
Days Sales Outstanding84.8564.351676.3471
Slightly volatile
Book Value Per Share28.1626.822518.5579
Slightly volatile
Operating Cash Flow Per Share4.264.05893.4497
Slightly volatile
Average Payables734.2 M699.2 M665.2 M
Slightly volatile
Capex To Depreciation0.380.40141.6659
Slightly volatile
PB Ratio0.840.88181.8136
Slightly volatile
EV To Sales1.821.17281.6864
Slightly volatile
Inventory Turnover9.287.05027.8461
Slightly volatile
Net Income Per Share0.870.9151.4959
Very volatile
Days Of Inventory On Hand35.5451.771647.4043
Slightly volatile
Payables Turnover11.7414.811514.2678
Slightly volatile
Sales General And Administrative To Revenue0.130.12240.1232
Slightly volatile
Average Inventory1.2 B1.2 B1.1 B
Slightly volatile
Research And Ddevelopement To Revenue0.0070.00950.0093
Slightly volatile
Capex To Revenue0.06120.03620.0944
Slightly volatile
Cash Per Share2.42.28491.7728
Slightly volatile
POCF Ratio5.125.38669.3555
Slightly volatile
Payout Ratio0.450.64910.4911
Pretty Stable
Capex To Operating Cash Flow0.280.29310.7514
Slightly volatile
Days Payables Outstanding28.6624.643125.6359
Slightly volatile
Income Quality2.573.22072.7301
Pretty Stable
ROE0.07350.03690.094
Slightly volatile
EV To Operating Cash Flow15.669.503713.5871
Slightly volatile
PE Ratio31.7223.894521.7013
Pretty Stable
Return On Tangible Assets0.030.03160.075
Slightly volatile
Earnings Yield0.03880.04190.0532
Pretty Stable
Intangibles To Total Assets0.580.49280.5174
Slightly volatile
Current Ratio1.531.39981.4219
Slightly volatile
Receivables Turnover3.825.6724.804
Slightly volatile
Graham Number28.2645.18745.0774
Slightly volatile
Shareholders Equity Per Share26.0324.79517.1389
Slightly volatile
Debt To Equity0.590.75490.8681
Very volatile
Capex Per Share1.251.18962.2764
Very volatile
Average Receivables1.4 B2.8 B2.7 B
Slightly volatile
Revenue Per Share34.5432.890725.6781
Slightly volatile
Interest Debt Per Share20.3819.410715.2299
Slightly volatile
Debt To Assets0.230.32780.3405
Very volatile
Enterprise Value Over EBITDA7.067.07299.0295
Pretty Stable
Short Term Coverage Ratios4.344.13272.4341
Pretty Stable
Price Earnings Ratio31.7223.894521.7013
Pretty Stable
Operating Cycle97.26116122
Slightly volatile
Price Book Value Ratio0.840.88181.8136
Slightly volatile
Days Of Payables Outstanding28.6624.643125.6359
Slightly volatile
Dividend Payout Ratio0.450.64910.4911
Pretty Stable
Price To Operating Cash Flows Ratio5.125.38669.3555
Slightly volatile
Pretax Profit Margin0.07890.05470.1023
Slightly volatile
Effective Tax Rate0.370.2990.3208
Slightly volatile
Company Equity Multiplier1.982.30282.4991
Pretty Stable
Long Term Debt To Capitalization0.270.30050.3735
Slightly volatile
Total Debt To Capitalization0.330.43020.4576
Very volatile
Debt Equity Ratio0.590.75490.8681
Very volatile
Quick Ratio1.231.03441.1248
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.152.27571.3139
Slightly volatile
Net Income Per E B T0.460.50890.552
Pretty Stable
Cash Ratio0.220.20850.1817
Slightly volatile
Cash Conversion Cycle76.4291.480297.1587
Pretty Stable
Operating Cash Flow Sales Ratio0.0960.12340.1294
Pretty Stable
Days Of Inventory Outstanding35.5451.771647.4043
Slightly volatile
Days Of Sales Outstanding84.8564.351676.3471
Slightly volatile
Cash Flow Coverage Ratios0.330.21680.2354
Pretty Stable
Price To Book Ratio0.840.88181.8136
Slightly volatile
Fixed Asset Turnover4.92.66393.9006
Slightly volatile
Capital Expenditure Coverage Ratio3.583.41191.8369
Slightly volatile
Price Cash Flow Ratio5.125.38669.3555
Slightly volatile
Enterprise Value Multiple7.067.07299.0295
Pretty Stable
Debt Ratio0.230.32780.3405
Very volatile
Cash Flow To Debt Ratio0.330.21680.2354
Pretty Stable
Price Sales Ratio0.630.66471.1591
Slightly volatile
Return On Assets0.03030.0160.0373
Slightly volatile
Asset Turnover0.730.5760.6171
Pretty Stable
Net Profit Margin0.04470.02780.0615
Slightly volatile
Gross Profit Margin0.360.2460.3192
Slightly volatile
Price Fair Value0.840.88181.8136
Slightly volatile
Return On Equity0.07350.03690.094
Slightly volatile

Fresenius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap10.1 B12.9 B16.6 B
Pretty Stable
Enterprise Value14.9 B20.4 B24.5 B
Pretty Stable

Fresenius Fundamental Market Drivers

Forward Price Earnings9.5329
Cash And Short Term Investments1.3 B

Fresenius Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue82.2 M78.1 M
Total Revenue19.3 B11.7 B
Cost Of Revenue14.6 B8.3 B
Sales General And Administrative To Revenue 0.12  0.13 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.04  0.06 
Revenue Per Share 32.89  34.54 
Ebit Per Revenue 0.07  0.13 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY